Waldman Lawrence 4
4 · Apyx Medical Corp · Filed Jul 11, 2022
Insider Transaction Report
Form 4
Waldman Lawrence
Director
Transactions
- Exercise/Conversion
Stock Option (Option to Buy)
2022-07-11−24,000→ 0 totalExercise: $2.54From: 2013-07-12Exp: 2022-07-12→ Common Stock (24,000 underlying) - Exercise/Conversion
Common Stock
2022-07-11$2.54/sh+24,000$60,960→ 37,563 total
Footnotes (1)
- [F1]Reporting Person was granted a stock option that vested and became exercisable over 3 years at a rate of 33.33% of the option on the anniversary date of each succeeding year.